TMDX TRANSMEDICS GROUP INC
2026Q1 · CUSIP 89377M109 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
411
Δ holders QoQ
-15
Breadth percentile
Top 90%
Whale holders
174
Δ whales
0
Inst. holding value
$3.6B
New positions
68
Closed positions
83
Price momentum (1Q)
-48.9%
Put / Call
9/9
Breadth history (34 quarters)
Past Lit Events & Aftermath 14 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 13% | -48.9% | — |
| 2025Q3 | Top 16% | +17.2% | -40.0% |
| 2025Q2 | Top 3% | -8.5% | +7.8% |
| 2024Q3 | Top 7% | -11.1% | +52.4% |
| 2024Q2 | Top 1% | -48.1% | -53.4% |
| 2024Q1 | Top 19% | +21.1% | -41.7% |
| 2023Q4 | Top 20% | +53.4% | +85.8% |
| 2023Q2 | Top 10% | +2.1% | +41.0% |
Options Sentiment
Put holders
9
QoQ: 0
Call holders
9
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
16.9
EPS (TTM)
$4.37
EPS YoY
+221.3%
Revenue (TTM)
$0.6B
Revenue YoY
+30.2%
Net margin
27.0%
ROE
34.8%
Debt ratio
65.6%
FCF (TTM)
$151M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.